Open Health has joined forces with health economics and outcomes research (HEOR) company Pharmerit International in a move that strengthens its existing market access capabilities.
OPEN Health has restructured its eight businesses into four specialist practices, in a move that will see it retire names such as LEC, Reynolds-MacKenzie and Harvey Walsh.